DALLAS -- Contrary to government claims, side effects happen more often with Crestor, a cholesterol-lowering drug that consumer advocates tried to get off the market earlier this year, a new analysis ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. A Food and Drug Administration advisory panel recommended today that ...

FDA approves Crestor’s generic rivals, much to Astrazeneca’s dismay The Food and Drug Administration on Wednesday approved several generic versions of the popular cholesterol-lowering drug Crestor, ...

SaveHealth reports on popular statin medications that lower cholesterol and cardiovascular risks, highlighting their benefits ...

Can we buy generic crestor 40 mg one day shipping Adjunct to diet in hypertriglyceridemia. Adjunct to diet in primary dysbetalipoproteinemia Type III hyperlipoproteinemia. Adjunct to diet to slow the ...

In a head-to-head test of two popular cholesterol-lowering statin drugs — Lipitor and Crestor — both medications worked equally well. Lipitor (atorvastatin) and Crestor (rosuvastatin) both effectively ...

The U.S. Food and Drug Administration today approved the first generic version of Crestor (rosuvastatin calcium) tablets for the following uses: in combination with diet for the treatment of high ...

Q. I just had a blood test, and my physician said my HDL cholesterol's low and my LDL is high - the reverse of what it ought to be. She prescribed a brand-name statin drug, Crestor. When I asked about ...

The rate of serious muscle damage in patients who took AstraZeneca Pharmaceutical's cholesterol drug Crestor was six times higher than with similar medicines, the consumer group Public Citizen said ...

MUMBAI, India The Food and Drug Administration has given tentative approval to a generic cholesterol drug made by Sun Pharmaceutical Industries. Sun announced Wednesday the tentative approval of ...

LONDON, Nov 1 (Reuters) - Anglo-Swedish drugmaker AstraZeneca Plc said on Thursday that Canada's Cobalt Pharmaceuticals was seeking U.S. regulatory permission to sell a generic version of its ...